Search GANX
Gain Therapeutics, Inc.
Nasdaq · CIK 1819411
Last close1.71
Daily change-0.01 (-0.58%)
10 Years gain-85.98%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
GANX · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
43.1Momentum
0.0Acceleration
0.0Confidence
73.0Annual Revenue4
Quarterly Revenue15
Annual CFO6
Balance SheetMissing
RankingLimited
Score Breakdown
Growth16.0 / 25
Quality6.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet13.1 / 15
Shareholder Economics5.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Negative FCF · HIGHLatest free cash flow is negative.
Gross margin compression · MEDIUMGross margin compressed by 5.6303 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 26925.7818 percentage points.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM-58.4%OK
Revenue CAGR 3Y24.09%OK
Gross Margin100%OK
Operating Margin-40,328.26%OK
FCF Margin-34,217.53%OK
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO0xOK
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenue5,906.17%OK
SBC / FCF-17.26%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $0.00 | -$18.71M | -$18.47M | n/a | n/a | n/a | n/a | n/a | 32.97M |
| 2025 FY Dec 31, 2024 | n/a | $0.00 | -$20.35M | -$18.87M | -$18.90M | n/a | n/a | n/a | n/a | 22.88M |
| 2024 FY Dec 31, 2023 | $55,180.00 | $55,180.00 | -$22.25M | -$18.87M | -$18.88M | 100% | -40,328.26% | -34,217.53% | n/a | 13.01M |
| 2023 FY Dec 31, 2022 | $132,640.00 | $140,108.00 | -$17.78M | -$14.69M | -$14.81M | 105.63% | -13,402.48% | -11,166.38% | n/a | 11.88M |
| 2022 FY Dec 31, 2021 | $133,928.00 | $164,994.00 | -$13.83M | -$12.37M | n/a | 123.2% | -10,323.59% | n/a | n/a | 10.17M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $55,180.00 | sum latest 4 fiscal quarters Revenue | OK | 0001558370-24-008132, 0001558370-24-011589 |
| Revenue Growth TTM | -58.4% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001558370-24-008132, 0001558370-24-011589 |
| Revenue CAGR 3Y | 24.09% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001558370-25-003823 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001558370-25-003823 |
| Gross Profit CAGR 3Y | 24.09% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001558370-25-003823 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001558370-24-008132, 0001558370-24-011589 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | 0001558370-24-008132, 0001558370-24-011589 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 100% | Gross Profit / Revenue | OK | 0001558370-24-008132, 0001558370-24-011589 |
| Operating Margin | -40,328.26% | Operating Income / Revenue | OK | 0001558370-24-008132, 0001558370-24-011589 |
| FCF Margin | -34,217.53% | (CFO - CapEx) / Revenue | OK | 0001558370-24-008132, 0001558370-24-011589 |
| Net Debt / CFO | 0x | Net Debt / CFO | OK | 0001558370-24-008132, 0001558370-24-011589 |
| SBC / Revenue | 5,906.17% | SBC / Revenue | OK | 0001558370-24-008132, 0001558370-24-011589 |
| SBC / FCF | -17.26% | SBC / FCF | OK | 0001558370-24-008132, 0001558370-24-011589 |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001558370-25-003823 |